Seuraa
Jode Goodridge
Jode Goodridge
Muut nimetJodie Peter Goodridge
Fate Therapeutics
Vahvistettu sähköpostiosoite verkkotunnuksessa fatetherapeutics.com
Nimike
Viittaukset
Viittaukset
Vuosi
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming
JA Wagner, M Rosario, R Romee, MM Berrien-Elliott, SE Schneider, ...
The Journal of clinical investigation 127 (11), 4042-4058, 2017
3542017
Critical role of CD2 co-stimulation in adaptive natural killer cell responses revealed in NKG2C-deficient humans
LL Liu, J Landskron, EH Ask, M Enqvist, E Sohlberg, JA Traherne, ...
Cell reports 15 (5), 1088-1099, 2016
2482016
Killer Ig-like receptor expression in uterine NK cells is biased toward recognition of HLA-C and alters with gestational age
AM Sharkey, L Gardner, S Hiby, L Farrell, R Apps, L Masters, J Goodridge, ...
The Journal of Immunology 181 (1), 39-46, 2008
1732008
HLA-F and MHC class I open conformers are ligands for NK cell Ig-like receptors
JP Goodridge, A Burian, N Lee, DE Geraghty
The Journal of Immunology 191 (7), 3553-3562, 2013
1662013
KIR2DL4 (CD158d) genotype influences expression and function in NK cells
JP Goodridge, CS Witt, FT Christiansen, HS Warren
The Journal of Immunology 171 (4), 1768-1774, 2003
1592003
Remodeling of secretory lysosomes during education tunes functional potential in NK cells
JP Goodridge, B Jacobs, ML Saetersmoen, D Clement, Q Hammer, ...
Nature communications 10 (1), 514, 2019
1372019
HLA-F complex without peptide binds to MHC class I protein in the open conformer form
JP Goodridge, A Burian, N Lee, DE Geraghty
The Journal of Immunology 184 (11), 6199-6208, 2010
1072010
Intrinsic functional potential of NK-cell subsets constrains retargeting driven by chimeric antigen receptors
VYS Oei, M Siernicka, A Graczyk-Jarzynka, HJ Hoel, W Yang, D Palacios, ...
Cancer immunology research 6 (4), 467-480, 2018
1002018
Maternal KIR repertoire is not associated with recurrent spontaneous abortion
CS Witt, J Goodridge, MG Gerbase-Delima, S Daher, FT Christiansen
Human reproduction 19 (11), 2653-2657, 2004
912004
Three common alleles of KIR2DL4 (CD158d) encode constitutively expressed, inducible and secreted receptors in NK cells
JP Goodridge, LJ Lathbury, NK Steiner, CN Shulse, P Pullikotil, ...
European journal of immunology 37 (1), 199-211, 2007
812007
Newtonian cell interactions shape natural killer cell education
JP Goodridge, B Önfelt, KJ Malmberg
Immunological reviews 267 (1), 197-213, 2015
792015
Growth in the Presence of Salicylate Increases Fluoroquinolone Resistance in Staphylococcus aureus
JE Gustafson, PV Candelaria, SA Fisher, JP Goodridge, TM Lichocik, ...
Antimicrobial Agents and Chemotherapy 43 (4), 990-992, 1999
791999
Analysis of HLA A* 02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial
AJ Gartland, S Li, J McNevin, GD Tomaras, R Gottardo, H Janes, Y Fong, ...
Journal of virology 88 (15), 8242-8255, 2014
772014
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway
JP Goodridge, N Lee, A Burian, CW Pyo, SS Tykodi, EH Warren, C Yee, ...
The Journal of Immunology 191 (4), 1567-1577, 2013
742013
FT596: translation of first-of-kind multi-antigen targeted off-the-shelf CAR-NK cell with engineered persistence for the treatment of B cell malignancies
JP Goodridge, S Mahmood, H Zhu, S Gaidarova, R Blum, R Bjordahl, ...
Blood 134, 301, 2019
722019
Killer Ig-like receptor 2DL4 does not mediate NK cell IFN-γ responses to soluble HLA-G preparations
MEL Le Page, JP Goodridge, E John, FT Christiansen, CS Witt
The Journal of Immunology 192 (2), 732-740, 2014
572014
Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma
F Cichocki, R Bjordahl, JP Goodridge, S Mahmood, S Gaidarova, ...
Nature communications 13 (1), 7341, 2022
522022
Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia
F Cichocki, JP Goodridge, R Bjordahl, S Mahmood, ZB Davis, ...
Blood, The Journal of the American Society of Hematology 140 (23), 2451-2462, 2022
512022
Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition
KJ Malmberg, E Sohlberg, JP Goodridge, HG Ljunggren
Immunogenetics 69 (8), 547-556, 2017
452017
Intra-lineage plasticity and functional reprogramming maintain natural killer cell repertoire diversity
A Pfefferle, B Jacobs, H Netskar, EH Ask, S Lorenz, T Clancy, ...
Cell reports 29 (8), 2284-2294. e4, 2019
442019
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20